Portfolio / Encare Biotech

Encare.gif


Encare Biotech is a spin-off of Utrecht UMC. Their lead product is a novel therapeutic monoclonal antibody against the EDA fragment of fibronectin.

EnCare Biotech aims to develop a new therapeutic antibody for the prevention of heart failure after acute myocardial infarction (heart attack).

Website

Company: encare biotech

Fund: II

Status: active

Team member:

Harrold van Barlingen

19.jpg
 

Technology:

Therapeutics

Icons-Creteria_Medical-technologymedical-devices.png